Clinical trial

Harvest of CTCs From MBC Patients Using the Parsortix™ PC1 System

NCT03427450

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2018-03-29

PhaseN/A

Study timeline

Study start (actual)2018-03-29Date precision: day

Registry last updated2023-06-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Healthy Volunteersunresolved

Breast Cancer, Metastaticunresolved

Interventions

Blood drawDIAGNOSTIC_TEST

Sponsors & collaborators

Angle plclead sponsor

Mapped research locations

HoustonTexas, United States1 ChicagoIllinois, United States1 Los AngelesCalifornia, United States1 RochesterNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03427450 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.